Yuyu Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Yuyu Pharma has a total shareholder equity of ₩127.9B and total debt of ₩34.5B, which brings its debt-to-equity ratio to 27%. Its total assets and total liabilities are ₩198.1B and ₩70.2B respectively. Yuyu Pharma's EBIT is ₩7.0B making its interest coverage ratio 4.2. It has cash and short-term investments of ₩36.2B.
Key information
27.0%
Debt to equity ratio
₩34.55b
Debt
| Interest coverage ratio | 4.2x |
| Cash | ₩36.22b |
| Equity | ₩127.90b |
| Total liabilities | ₩70.16b |
| Total assets | ₩198.06b |
Recent financial health updates
Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden
Apr 02
Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly
Dec 20Recent updates
Concerns Surrounding Yuyu Pharma's (KRX:000220) Performance
Aug 24Pinning Down Yuyu Pharma, Inc.'s (KRX:000220) P/S Is Difficult Right Now
Aug 07Here's Why Yuyu Pharma (KRX:000220) Has A Meaningful Debt Burden
Apr 02Should Yuyu Pharma, Inc. (KRX:000220) Be Part Of Your Dividend Portfolio?
Mar 08The Yuyu Pharma (KRX:000220) Share Price Has Gained 12% And Shareholders Are Hoping For More
Feb 10
We Wouldn't Rely On Yuyu Pharma's (KRX:000220) Statutory Earnings As A Guide
Jan 07Yuyu Pharma (KRX:000220) Seems To Use Debt Quite Sensibly
Dec 20Would Yuyu Pharma, Inc. (KRX:000220) Be Valuable To Income Investors?
Dec 03Financial Position Analysis
Short Term Liabilities: A000220's short term assets (₩102.7B) exceed its short term liabilities (₩62.8B).
Long Term Liabilities: A000220's short term assets (₩102.7B) exceed its long term liabilities (₩7.3B).
Debt to Equity History and Analysis
Debt Level: A000220 has more cash than its total debt.
Reducing Debt: A000220's debt to equity ratio has increased from 24.2% to 27% over the past 5 years.
Debt Coverage: A000220's debt is well covered by operating cash flow (49.4%).
Interest Coverage: A000220's interest payments on its debt are well covered by EBIT (4.2x coverage).